BACKGROUND: Albumin and alpha1-microglobulin (alpha1M) are absorbed by two specific receptors in tubular epithelial cells. Any cell injury will disturb the reabsorption of these proteins, The increased urinary excretions of albumin or alpha1M could thus serve as a marker of subclinical graft lesions and as an early indicator of chronic allograft dysfunction. METHODS: We measured 24-hour urinary excretions of albumin, alpha1M, and transforming growth factor (TGF)-beta1 at 6 months after transplantation in 79 renal-graft recipients and recorded the changes in 24-hour creatinine clearance an average 51 (range 14-72) posttransplant follow-up months. RESULTS: At 6 months from transplantation, 46 of 79 (58%) patients were normoalbuminuric, 25 (32%) microalbuminuric, and 8 (10%) macroalbuminuric. In normoalbuminuric patients, urinary alpha1M/creatinine ratio was 10 times, and TGF-beta1/creatinine ratio approximately 5 times, higher than in the healthy subjects but lower than in albuminuric patients. In all patients, urinary alpha1M correlated with urinary TGF-beta1 (r=0.508, P<0.001), with albumin (r=0.220, P<0.05), and with the annual changes in 24-hour creatinine clearance (r=-0.273, P<0.05). During follow-up, renal function deteriorated in 20 of 33 (60%) patients with alpha1M/creatinine ratio greater than 5 mg/mmol, but only in 1 of 46 (2%) patients whose ratio was less than 5 mg/mmol (P<0.01), giving the ratio 5 mg/mmol or greater a 95% sensitivity to detect patients with poor long-term outcome. CONCLUSIONS: We show proximal tubular injury, measured by increased urinary alpha1M, to be present even in normoalbuminuric patients and to be associated with increased excretion of TGF-beta1 and with the annual deterioration of glomerular filtration rate. These findings show increased alpha1M/creatinine ratio to be an early and sensitive indicator of poor long-term outcome in renal-transplant patients.
BACKGROUND: Albumin and alpha1-microglobulin (alpha1M) are absorbed by two specific receptors in tubular epithelial cells. Any cell injury will disturb the reabsorption of these proteins, The increased urinary excretions of albumin or alpha1M could thus serve as a marker of subclinical graft lesions and as an early indicator of chronic allograft dysfunction. METHODS: We measured 24-hour urinary excretions of albumin, alpha1M, and transforming growth factor (TGF)-beta1 at 6 months after transplantation in 79 renal-graft recipients and recorded the changes in 24-hour creatinine clearance an average 51 (range 14-72) posttransplant follow-up months. RESULTS: At 6 months from transplantation, 46 of 79 (58%) patients were normoalbuminuric, 25 (32%) microalbuminuric, and 8 (10%) macroalbuminuric. In normoalbuminuric patients, urinary alpha1M/creatinine ratio was 10 times, and TGF-beta1/creatinine ratio approximately 5 times, higher than in the healthy subjects but lower than in albuminuric patients. In all patients, urinary alpha1M correlated with urinary TGF-beta1 (r=0.508, P<0.001), with albumin (r=0.220, P<0.05), and with the annual changes in 24-hour creatinine clearance (r=-0.273, P<0.05). During follow-up, renal function deteriorated in 20 of 33 (60%) patients with alpha1M/creatinine ratio greater than 5 mg/mmol, but only in 1 of 46 (2%) patients whose ratio was less than 5 mg/mmol (P<0.01), giving the ratio 5 mg/mmol or greater a 95% sensitivity to detect patients with poor long-term outcome. CONCLUSIONS: We show proximal tubular injury, measured by increased urinary alpha1M, to be present even in normoalbuminuric patients and to be associated with increased excretion of TGF-beta1 and with the annual deterioration of glomerular filtration rate. These findings show increased alpha1M/creatinine ratio to be an early and sensitive indicator of poor long-term outcome in renal-transplant patients.
Authors: Luis F Quintana; Josep M Campistol; Maria P Alcolea; Elisenda Bañon-Maneus; Amandaé Sol-González; Pedro R Cutillas Journal: Mol Cell Proteomics Date: 2009-04-07 Impact factor: 5.911
Authors: H Amer; J C Lieske; A D Rule; W K Kremers; T S Larson; C R Franco Palacios; M D Stegall; F G Cosio Journal: Am J Transplant Date: 2013-02-15 Impact factor: 8.086
Authors: Edmond O'Riordan; Tatyana N Orlova; Natalia Mendelev; Daniel Patschan; Rowena Kemp; Praveen N Chander; Rena Hu; Gang Hao; Steven S Gross; Renato V Iozzo; Veronica Delaney; Michael S Goligorsky Journal: Proteomics Clin Appl Date: 2008-07 Impact factor: 3.494
Authors: M Park; R Katz; M G Shlipak; D Weiner; R Tracy; V Jotwani; J Hughes-Austin; F Gabbai; C Y Hsu; M Pfeffer; N Bansal; A Bostom; O Gutierrez; M Sarnak; A Levey; J H Ix Journal: Am J Transplant Date: 2017-04-26 Impact factor: 8.086
Authors: Joseph D P Willet; Watchara Pichitsiri; Sarah E Jenkinson; John G Brain; Katrina Wood; Abd A Alhasan; Julia Spielhofer; Helen Robertson; Simi Ali; John A Kirby Journal: J Leukoc Biol Date: 2012-11-27 Impact factor: 4.962